--- title: "Enanta制藥 (ENTA.US) — 財務報表" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/ENTA.US/norm.md" symbol: "ENTA.US" name: "Enanta制藥" parent: "https://longbridge.com/zh-HK/quote/ENTA.US.md" datetime: "2026-05-19T20:39:22.607Z" locales: - [en](https://longbridge.com/en/quote/ENTA.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ENTA.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ENTA.US/norm.md) --- # Enanta制藥 (ENTA.US) — 財務報表 ## 損益表 (USD) | 指標 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -0.4508 | -0.4153 | -0.8746 | -0.8540 | -1.06 | | ROE | -43.07% | -49.92% | -103.89% | -84.51% | -88.21% | | 營業收入 | 17.16M | 18.61M | 15.13M | 18.31M | 14.93M | | 凈利潤 | -13.09M | -11.94M | -18.70M | -18.25M | -22.64M | | 營業利潤 | -11.85M | -11.25M | -18.39M | -18.89M | -24.53M | | 毛利率 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | | 凈利率 | -76.29% | -64.13% | -123.64% | -99.68% | -151.71% | | 利潤含金量 | - | - | - | -107.92% | - | ## 資產負債表 (USD) | 指標 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | 資產與負債 | 314.70M | 329.50M | 280.73M | 301.03M | 322.99M | | 權益乘數 | 2.70 | 2.60 | 4.34 | 3.80 | 3.45 | | 每股凈資產 | 4.01 | 4.36 | 3.03 | 3.71 | 4.38 | | 資產周轉率 | 0.2171 | 0.1975 | 0.1987 | 0.1852 | 0.1750 | | 現金及短投 | 163.77M | 185.85M | 188.86M | 204.11M | 193.38M | | 存貨與應收 | - | - | - | - | - | | 長期投資 | 69.55M | 71.31M | 72.94M | 74.87M | 76.67M | | 凈債務 | -40.40M | -48.72M | 12.19M | 2.99M | 22.77M | ## 現金流量表 (USD) | 指標 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | | --- | --- | --- | --- | --- | --- | | 經營現金流 | -7.16M | -11.70M | -6.49M | 17.51M | -13.49M | | 投資現金流 | 11.94M | -47.30M | 2.30M | -26.48M | -4.37M | | 融資現金流 | -7.29M | 64.14M | -8.32M | -6.42M | -6.89M | | 自由現金流 | -2.51M | -4.74M | -4.21M | 25.64M | -12.24M | | 現金流充裕率 | -47706.67% | -8181.12% | -445.06% | 11294.19% | -531.44% | | 舉債與償債 | - | - | - | - | - | | 資本支出 | -15000.00 | -143000.00 | -1.46M | -155000.00 | -2.54M |